Our fluorinated intermediates can be used
to enhance the biological properties of a wide range of pharmaceuticals
and agrochemicals, making it easy to add the valuable properties
of the C-F bond to a variety of biologically active molecules.
Physical, chemical, and
biological properties of compounds including surface energies, reactivity,
polarity, and thermal stability can be greatly altered by the substitution
of one or more fluorine atoms. Thus, it's not surprising that the
positive effects of fluorine are found in over 20% of pharmaceuticals
and over 30% of agrochemicals under development.
Incorporating fluorine
into a bioactive pharmaceutical or agricultural compound can often
improve lipophilicity, reduce toxicity and increase efficacy. Our
range of organic building blocks based on CF2 and CF3
groups make it safe, simple, and economical to propitiously place
fluorine at a particular position in a molecule.
Fluorinated compounds
are playing a significant role in the development of new anti-cancer,
anti-viral, anti-inflammatory, anti-fertility, and central nervous
system drugs among others. In modern crop protection, fluorine containing
agrochemicals include herbicides, insecticides, and fungicides.
Selectively fluorinated compounds are being
used extensively in the development of new pharmaceuticals and agrochemicals
because these compounds exhibit dramatically improved potency when
compared to non-fluorinated analogues. This often results in cost
savings and smaller dosage requirements.
Please click on the appropriate chemical
intermediate to review the technical datasheet:
- Tetrachloropropane
(TCP) - TCP is a selectively chlorinated propane that is used
as an industrial chemical to produce easily alterable products.
The unique position of chlorine allows selective reactions, creating
new intermediates for the synthesis of pharmaceutical and agricultural
substances.
Individuals with asthma and chronic obstructive
pulmonary disease such as bronchitis or emphysema depend on metered-dose
inhalers (MDIs) to deliver medicine to their lungs. Our HFC-227ea
medical gas, also known as Heptafluoropropane, is used as a propellant
in many MDI formulations to deliver the proper amount of medication.
HFC-227ea was developed to replace ozone-depleting compounds such
as CFC-11, CFC-12, CFC-114, HCFC-22, and HCFC-142b in aerosol propellant
applications.
Manufactured in accordance
with current Good Manufacturing Procedures (cGMP) for active pharmaceutical
ingredients, HFC-227ea is approved by the U. S. Food and Drug Administration
and is compatible with a wide range of medications.
Many of the world's largest
pharmaceutical companies have adopted HFC-227ea as part of their
changeover to CFC-free inhalers. The vapor pressure, density, and
solubility of HFC-227ea are the ideal physical and chemical properties
necessary for the proper delivery of medicine.
To review the technical
datasheet on high-purity HFC-227ea, please click
here.